Sera Prognostics
For the last 15 years, Ben has represented Myriad Genetics, Inc., beginning as a law clerk, initially focusing on intellectual property, and ultimately advancing to become General Counsel of a global molecular diagnostics enterprise. Mr. Jackson is viewed as a thought leader who has written and presented extensively in the area of molecular diagnostics intellectual property, while also possessing broad experience in a wide range of legal matters, including patent and commercial litigation, M&A transactions, interactions with government and private payers, corporate legal policies and contracting.
This person is not in any teams
Sera Prognostics
Sera Prognostics is a leading proteomic and bioinformatics company dedicated to improving the lives of women and babies through precision biomarker-based tests designed to enhance pregnancy care. Sera’s vision is to deliver pivotal information in early pregnancy to physicians, to help them to improve the health of their patients and reduce costs of healthcare delivery.